Objectives: To determine the relationship between maternal serum uric acid levels and fetal/neonatal complications in women with pre-eclampsia/eclampsia, and to establish a predictive threshold value.
| INTRODUCTION
Uric acid is the final substance in the process of purine metabolism. 1, 2 Elevated levels are considered to be an early biomarker of kidney damage in women with pre-eclampsia and also a factor in predicting fetal death. 1, 3 The role of uric acid as the possible cause of maternal and fetal deaths in pre-eclamptic patients (10%-15% and 5.9%, respectively) is controversial and the subject of ongoing study. In Vietnam, although there have been many studies on preeclampsia in terms of prevention, early diagnosis, and pregnancy outcomes, there are limited studies that have investigated uric acid concentration and its role in predicting severe fetal complications in pre-eclamptic patients. The aim of the present study was to determine the relationship between maternal serum uric acid levels and fetal/ neonatal complications in women with pre-eclampsia/eclampsia, and to establish a predictive value for these complications.
| MATERIALS AND METHODS
A diagnostic test and historical cohort study conducted by prospective cross-sectional data collection on singleton pregnant women with pre-eclampsia/eclampsia admitted to the Department of Obstetrics P<0.05 was considered statistically significant.
| RESULTS
During the study period, 205 pregnant women with pre-eclampsia/ eclampsia met the eligibility criteria and were recruited consecutively.
The general characteristics of the study population and the fetal/neonatal complications are shown in Table 1 . The mean age of the study participants was 30.6 ± 6.7 years, and there was no significant difference in age between group 1 (pre-eclampsia) and group 2 (severe preeclampsia/eclampsia). Differences in parity and BMI were also not significant between the groups.
Uric acid concentration was significantly higher in group 2 compared with group 1 (427.60 ± 113.54 vs 328.99 ± 88.49; P<0.001).
IUGR was the most common fetal/neonatal complication, accounting for 25.9% (n=53), followed by preterm birth at 22.4% (n=46). Apgar score of less than 7 was established for 199 live neonates owing to 6 cases of fetal death. Table 2 ).
For general fetal/neonatal complications (occurrence of at least one of the other five events), the AUC was 0.752 and the threshold uric acid level was 393 μmol/L, with 64.4% sensitivity and 79.5% specificity (Fig. 1) .
The relationship between fetal outcomes and uric acid threshold of 393 μmol/L is shown in There was no association between uric acid level and maternal factors such as age, parity, or delivery method ( Table 4 ). The only associated factor was severe pre-eclampsia/eclampsia (OR 5.188, 95% CI 2.790-9.649; P<0.001). 
| DISCUSSION
This cross-sectional study of 205 pregnant women with preeclampsia/eclampsia aimed to assess the role of maternal serum uric acid levels in predicting pregnancy outcomes. The study was also designed to establish a predictive threshold value of maternal uric acid levels and occurrence of fetal complications. The association of biomarkers, including uric acid, with adverse outcomes in pre-eclamptic pregnant women is discussed in ACOG guidelines
10
; however, its utility as a diagnostic marker is still debated.
T A B L E 1 General characteristics of the study population and fetal/neonatal outcomes. Abbreviations: AUC, area under the curve; IUGR, intrauterine growth restriction.
The occurrence of pregnancy outcomes in the present study were: preterm birth rate (22.4%), IUGR (25.9%), Apgar score less than 7 (9.0%), fetal death (2.9%), and neonatal death (4.9%). Other studies have reported similarly, with preterm birth ranging from 15% to 67%, IUGR ranging from 10% to 25%, and fetal mortality ranging from 1% to 2%. In the present study, a threshold of 393 μmol/lL was not a predictive factor for fetal death (OR 1.803, 95% CI 0.355-9.168).
However, high uric acid concentration increased the risk of neonatal mortality by over sevenfold (OR 7.818, 95% CI 1.614-37.867).
This result is controversial owing to the wide confidence interval.
In another study, maternal serum uric acid levels were increased in 86.4% of cases of perinatal. The uric acid threshold in the present study was a good predictor of severity of pre-eclampsia/eclampsia (OR 5.188, 95% CI 2.790-9.649). These findings were much higher than those of Hawkins et al., 7 who reported that hyperuricemia indicated an increased risk of severe hypertension (OR 1.4, 95% CI 1.0-1.9). However, there was no association between our threshold value and cesarean or vaginal delivery.
In multivariable logistic regression analysis adjusted for maternal age, grade of pre-eclampsia, and parity, serum uric acid was a good prognostic marker at the threshold of 393 μmol/L for general fetal/neonatal complications (OR 4.399, 95% CI 2.137-9.052). For each individual outcome, serum uric acid was a good prognostic marker for IUGR, preterm birth, neonatal death, and low Apgar score.
The present study had some limitations, such as missing maternal data for preconception and prenatal care, which made the assessment of maternal risks more difficult.
In conclusion, maternal serum uric acid concentration was a good prognostic factor for monitoring and prognosis of fetal/neonatal outcomes in women with pre-eclampsia/eclampsia. There was a relationship between high uric acid level and the risk of preterm birth, low
Apgar index, IUGR, and neonatal death, but not fetal death.
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T A B L E 5 Multivariable logistic regression for predicted fetal/ neonatal outcomes based on uric acid threshold of 393 μmol/L. 
